Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
about
Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate ImmunityTargeting C-Type Lectin Receptors for Cancer ImmunityGlycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic CellsRole of the C-type lectin receptors MCL and DCIR in experimental colitisImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesIs infant immunization by breastfeeding possible?Sweetened antibodies against humoral autoimmunity: sialylated antibodies are required for IVIg-mediated therapy.Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia.IgG subclasses and allotypes: from structure to effector functions.Glycosylation of immunoglobulin G determines osteoclast differentiation and bone lossProtection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.Borrelia burgdorferi induces a type I interferon response during early stages of disseminated infection in mice.Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation.Production of α2,6-sialylated IgG1 in CHO cellsHeme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.Tregitope peptides: the active pharmaceutical ingredient of IVIG?Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patientsSignalling versatility following self and non-self sensing by myeloid C-type lectin receptors.The protective role of immunoglobulins in fungal infections and inflammation.Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.Dendritic cells revisited in human allergic rhinitis and asthma.bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression.IVIG-mediated effector functions in autoimmune and inflammatory diseases.The Emerging Importance of IgG Fab Glycosylation in Immunity.Innate Immune System at the Maternal-Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes.The potential of intravenous immunoglobulins for cancer therapy: a road that is worth taking?Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Immunoglobulin Glycosylation Effects in Allergy and Immunity.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency.IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.Absence of DCIR1 reduces the mortality rate of endotoxemic hepatitis in mice.Unlocking the bone: Fcγ-receptors and antibody glycosylation are keys to connecting bone homeostasis to humoral immunity.Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?The Role of Autoantibodies in Bone Metabolism and Bone Loss.The IVIg dilemma: a way out?Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
P2860
Q26781290-588759E7-BA05-4924-926B-1C9D12645633Q26784483-22D42D3E-62EA-416B-BABD-FAC56622E257Q27303888-196C4FCA-BBEF-4EF6-B77E-574CCE1F3CDBQ27317611-B66F87DD-456A-487E-AE28-3E40A2E04422Q28069362-31D26B5C-4F8E-4888-97BC-F9C67EB01F47Q28081718-047BB9ED-589C-4BCA-A2C4-0112398453B9Q33414406-E45BA045-6AED-471D-A749-7CB1BCDA4890Q33420853-41410198-1AEF-463B-AE1B-4784DF80EF74Q33437093-F4D5E342-EC4F-4E28-ACB7-18ACD15907FEQ34368678-52272D74-EA3E-41F7-9151-03EB5C688630Q35311994-C861D32D-2CAE-4054-BF5F-31189617849AQ35590264-B242CE98-2D4F-4C9C-B040-3A6FC21D4F78Q35950343-6A9673A5-79CE-483B-81AF-34A1A8593868Q36085055-18D595EB-4328-4562-BDB9-533476EF822AQ36213335-CC6794ED-F50B-44EE-8CC9-8CEBFA9876D8Q36500575-639E900D-6B95-4F64-BF85-8E3A663D1997Q37456938-F4748F36-B697-4DAA-BA7D-27FDDD960C4AQ37713650-85ED098C-EBB2-4929-A809-91DD63A08FDCQ37732919-A3540A1B-25D2-4757-8F8F-B505001E409DQ38255641-58F7DA53-157D-43C4-AB56-02C0BD0BCED1Q38268922-480D5763-F706-4588-8417-54BA1217452EQ38344833-5D23D3B6-79C6-4F27-9327-56611FD67AA1Q38478867-0C0C0303-D505-4FE2-BF5C-E63104A7F7D9Q38596794-C870C0DD-0B59-438F-A98F-5DB8DBEB51A3Q38615353-4A3C1CA7-FECA-4CA7-BE95-68BDF96A7DBCQ38699812-35B69789-9EDF-4037-970D-F48A8C2D157FQ38724772-934D8A17-3A57-4185-AA91-AB3BB0154A31Q38816011-ED1B637D-C1D7-4070-8416-B22FC00FEF32Q38824186-9196A463-4888-4B1E-99AF-7304EA6B6C8EQ38900642-C23CCE73-B2B2-406C-BC97-D875278DE52FQ38994739-57D450D1-F428-4827-A42D-EA6B81B10F46Q39062945-CB5DF1AA-D9D8-4DE6-9462-9E0EF73A2405Q40039287-ACBB9965-4F1D-429B-A787-20DE125624B2Q40108236-5035C5AF-256D-47A7-8786-7E8810292CE0Q40356360-DC1D4579-5B4C-4428-9E9A-80812C06D461Q41787449-3D4614D7-DD46-4B68-B354-1EFE95268886Q42375731-ADCB021E-615C-4027-BC1F-A18A7B73F4E7Q47331159-1B6BDFD7-B239-4BC8-9352-1DE8D4330550Q47722906-233CC616-6DAF-476E-938E-24EAE561EF6EQ47804590-7F278D32-E05F-46EC-8D5E-51B40734F05E
P2860
Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@en
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@nl
type
label
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@en
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@nl
prefLabel
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@en
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@nl
P2093
P1476
Dendritic cell immunoreceptor: ...... duction of regulatory T cells.
@en
P2093
Aidan Ablona
Amir H Massoud
Bruce D Mazer
Ciriaco A Piccirillo
Fazila Chouiali
Haydar Alturaihi
Madelaine Yona
Walid Mourad
P304
P356
10.1016/J.JACI.2013.09.029
P407
P577
2013-11-08T00:00:00Z